Pectinase responsive nanoplatform for oral targeted delivery 5-aminosalicylic acid and zinc coordination driven nanozyme in inflammatory bowel disease treatment. [PDF]
Lin Y +11 more
europepmc +1 more source
Persistence of newly prescribed 5-aminosalicylic acid in patients with ulcerative colitis: A nationwide comprehensive database study. [PDF]
Noda T +6 more
europepmc +1 more source
Significance of 5-Aminosalicylic Acid Intolerance in the Clinical Management of Ulcerative Colitis.
Mikami Y +5 more
europepmc +1 more source
Unveiling the Unexplored Multifactorial Potential of 5-Aminosalicylic Acid in Diabetic Wound Therapy. [PDF]
Sanapalli BKR +3 more
europepmc +1 more source
Characteristics of Mucosa-Associated Microbiota in Ulcerative Colitis Patients with 5-Aminosalicylic Acid Intolerance. [PDF]
Matsumoto H +9 more
europepmc +1 more source
Risk factors for non-responsiveness to 5-aminosalicylic acid in patients with ulcerative colitis identified using retrospective clinical study and Mendelian randomization. [PDF]
Ye ZN +7 more
europepmc +1 more source
Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis. [PDF]
Murray A +4 more
europepmc +1 more source
Efficacy of Dose Escalation of Oral 5-Aminosalicylic Acid for Ulcerative Colitis With a Mayo Endoscopic Subscore of 1: An Open Label Randomized Controlled Trial. [PDF]
Fukuda T +19 more
europepmc +1 more source
Successful Treatment of Refractory Ulcerative Colitis With 5-Aminosalicylic Acid Intolerance and Biologic Therapy Resistance Using Combined Granulocyte and Monocyte Adsorptive Apheresis. [PDF]
Tanaka T +3 more
europepmc +1 more source
Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis. [PDF]
Murray A +4 more
europepmc +1 more source

